MapLight Therapeutics

MLPT Insider Catalyst4 Buys $50M More Stock at $11.38

by
SEC Form 4 filing document showing an insider stock purchase at MapLight Therapeutics

Catalyst4, Inc., an insider at MapLight Therapeutics, Inc. (MLPT), disclosed a fresh open-market purchase in a Form 4 filing with the SEC. The transaction, dated August 14, 2026, shows Catalyst4 buying 4,400,000 shares at $11.38 apiece, a total outlay of $50,072,000.00 paid with the insider’s own funds. Following the purchase, Catalyst4 reports beneficial ownership of … Read more

MLPT Insider Catalyst4 Buys $13M as Cluster Buy Tops $15.3M

by
Chart and document icons representing SEC Form 4 insider stock purchase filing for MapLight Therapeutics (MLPT)

MapLight Therapeutics, Inc. (MLPT) is drawing attention this week after a fresh Form 4 filing showed insider entity Catalyst4, Inc. purchasing 1,000,000 shares of the company on the open market on July 30, 2026. The purchase price came to $13.00 per share, for a total outlay of $13,000,000.00 — money spent directly by the insider, … Read more